Daiwa Securities Group Inc. Enanta Pharmaceuticals Inc Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$41.02 - $58.65 $1,271 - $1,818	31 Added 81.58%	69 $4,000
Q4 2020 Feb 04, 2021	SELL	$41.16 - $47.47 $3,004 - $3,465	-73 Reduced 65.77%	38 $2,000
Q4 2019 Jan 31, 2020	SELL	$57.95 - $66.61 $753 - $865	-13 Reduced 10.48%	111 $7,000
Q1 2019 Apr 26, 2019	BUY	$69.08 - $105.66 $1,312 - $2,007	19 Added 18.1%	124 $12,000
Q1 2018 May 02, 2018	BUY	$57.91 - $92.15 $6,080 - $9,675	105 New	105 $8,000

107

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $102M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.